These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34763274)

  • 1. Comment on "The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study".
    Zang H; Yan W; Xie W
    J Clin Anesth; 2022 Feb; 76():110572. PubMed ID: 34763274
    [No Abstract]   [Full Text] [Related]  

  • 2. The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study.
    Abdelbaser I; Mageed NA; Elfayoumy SI; Elgamal MF; Elmorsy MM; Taman HI
    J Clin Anesth; 2021 Aug; 71():110231. PubMed ID: 33735670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.
    Poidinger B; Kotzinger O; Rützler K; Kleinsasser A; Zierer A; Knotzer H
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):328-333. PubMed ID: 30122612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled levosimendan versus intravenous levosimendan in patients with pulmonary hypertension undergoing mitral valve replacement.
    Kundra TS; Nagaraja PS; Bharathi KS; Kaur P; Manjunatha N
    Ann Card Anaesth; 2018; 21(3):328-332. PubMed ID: 30052230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
    Kundra TS; Prabhakar V; Kaur P; Manjunatha N; Gandham R
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2123-2129. PubMed ID: 30098861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery.
    Ebade AA; Khalil MA; Mohamed AK
    J Anesth; 2013 Jun; 27(3):334-9. PubMed ID: 23223915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan and systemic vascular resistance in cardiac surgery patients: a systematic review and meta-analysis.
    Terbeck S; Heinisch PP; Lenz A; Friess JO; Guensch D; Carrel T; Eberle B; Erdoes G
    Sci Rep; 2019 Dec; 9(1):20343. PubMed ID: 31889123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.
    Ersoy O; Boysan E; Unal EU; Yay K; Yener U; Cicekcioglu F; Katircioglu F
    Cardiovasc J Afr; 2013 Aug; 24(7):260-4. PubMed ID: 24217302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
    Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
    Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.
    van Diepen S; Mehta RH; Leimberger JD; Goodman SG; Fremes S; Jankowich R; Heringlake M; Anstrom KJ; Levy JH; Luber J; Nagpal AD; Duncan AE; Argenziano M; Toller W; Teoh K; Knight JD; Lopes RD; Cowper PA; Mark DB; Alexander JH
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2302-2309.e6. PubMed ID: 31358329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
    Weber C; Esser M; Eghbalzadeh K; Sabashnikov A; Djordjevic I; Maier J; Merkle J; Choi YH; Madershahian N; Liakopoulos O; Deppe AC; Wahlers TCW
    Thorac Cardiovasc Surg; 2020 Aug; 68(5):401-409. PubMed ID: 31770777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
    Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
    Thorlacius EM; Suominen PK; Wåhlander H; Keski-Nisula J; Vistnes M; Ricksten SE; Synnergren M; Romlin BS; Castellheim A
    Pediatr Crit Care Med; 2019 Oct; 20(10):947-956. PubMed ID: 31274775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.
    Solina A; Papp D; Ginsberg S; Krause T; Grubb W; Scholz P; Pena LL; Cody R
    J Cardiothorac Vasc Anesth; 2000 Feb; 14(1):12-7. PubMed ID: 10698385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan and severe pulmonary hypertension during open heart surgery.
    Cicekcioglu F; Parlar AI; Ersoy O; Yay K; Hijazi A; Katircioglu SF
    Gen Thorac Cardiovasc Surg; 2008 Nov; 56(11):563-5. PubMed ID: 19002758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.
    Jawitz OK; Stebbins AS; Raman V; Alhanti B; van Diepen S; Heringlake M; Fremes S; Whitlock R; Meyer SR; Mehta RH; Stafford-Smith M; Goodman SG; Alexander JH; Lopes RD
    Am Heart J; 2021 Jan; 231():18-24. PubMed ID: 33127531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
    Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Kelleher A; Collins P; Li J; Bush A; Shinebourne EA; Redington AN
    Circulation; 1999 Aug; 100(7):749-55. PubMed ID: 10449698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.